Pantoprazole is a generic delayed-release oral tablet prescribed for certain conditions affecting the gastrointestinal system. It’s available as the brand-name drug Protonix. The cost of pantoprazole ...

Sun Pharmaceutical is introducing delayed-release pantoprazole oral suspension in a dosage strength of 40 mg. The product is the first generic of Pfizer’s Protonix oral delayed-release suspension 40 ...

Wyeth seeks to recoup lost profit from Teva Pharmaceutical's generic Protonix launch A patent dispute over the heartburn drug Protonix escalated Monday when Wyeth said it will sue to recover lost ...

NEW YORK (Reuters) - Wyeth said on Tuesday it had launched a U.S. generic form of its blockbuster Protonix heartburn drug, even as it continues legal action to stop other companies from selling their ...

TEL AVIV, Dec 24 (Reuters) - Israel's Teva Pharmaceutical Industries Ltd on Monday raised its 2007 earnings outlook due to the launch of its generic version of Wyeth's ulcer drug Protonix. The product ...

TORONTO, Dec. 22, 2010 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), today announced that it has notified the U.S. Food and Drug Administration (FDA) that it has ...

TORONTO, Oct. 18, 2010 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) today announced that the Food and Drug Administration (FDA) has accepted for filing its ...

The bioavailability of pantoprazole when administered as a suspension in sodium bicarbonate solution and as the oral tablet was studied. In an open-label, randomized, two-period crossover study, ...

After Teva launched generic Protonix on Christmas Eve, fought with Wyeth about it, then made a surprise exit, we thought the drama was over. But this week we get another act, thanks to the the ...

Objective and design: The use of proton pump inhibitors in acid-related diseases such as peptic ulcer or erosive reflux oesophagitis is well established. The aim of the current nationwide, multicentre ...